TP53 and malignant peripheral nerve sheath tumor: In MPNST, we observed recurrent mutations in NF1, SUZ12, EED, TP53 and CDKN2A in 92%, 42%, 33%, 50% and 58% respectively of our study population (Fig. 1, Tables S2 and S3).